Syntheses, Crystal Structures of Copper (II)-based Complexes of Sulfonamide Derivatives and Their Anticancer Effects Through the Synergistic Effect of Anti-angiogenesis, Anti-inflammation, Pro-apoptosis and Cuproptosis
Ai-Qiu Liao, Juan Wen, Jing-Chen Wei, Bing-Bing Xu, Nan Jin, Hong-Yu Lin, Xiu-Ying Qin
{"title":"Syntheses, Crystal Structures of Copper (II)-based Complexes of Sulfonamide Derivatives and Their Anticancer Effects Through the Synergistic Effect of Anti-angiogenesis, Anti-inflammation, Pro-apoptosis and Cuproptosis","authors":"Ai-Qiu Liao, Juan Wen, Jing-Chen Wei, Bing-Bing Xu, Nan Jin, Hong-Yu Lin, Xiu-Ying Qin","doi":"10.1016/j.ejmech.2024.116954","DOIUrl":null,"url":null,"abstract":"Three novel copper(II)-based complexes <strong>Cu-1</strong>, <strong>Cu-2</strong>, and <strong>Cu-3</strong> containing sulfamethoxazole or sulfamethazine ligand were obtained, and their single structures were characterized. Both <strong>Cu-1</strong> and <strong>Cu-3</strong> show a broad spectrum of cytotoxicity than <strong>Cu-2</strong>, and <strong>Cu-1</strong> is more cytotoxic than <strong>Cu-3</strong>. What's interesting is that <strong>Cu-1</strong> can exhibit obvious inhibitory effect on the growth of human triple-negative breast cancer in vivo and vitro through anti-proliferative, anti-angiogenic, anti-inflammatory, pro-apoptotic and cuproptotic synergistic effects. Though <strong>Cu-3</strong> shows no significant cytotoxicity against MDA-MB-231 cells, it can significantly inhibit the growth of SKOV3 cells in vitro by down-regulating the expression of some key proteins in the VEGF/VEGFR2 signaling pathway and the expression of some pro-inflammatory cytokines, and by disrupting the balance of intracellular reactive oxygen species levels.","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":6.0000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejmech.2024.116954","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Three novel copper(II)-based complexes Cu-1, Cu-2, and Cu-3 containing sulfamethoxazole or sulfamethazine ligand were obtained, and their single structures were characterized. Both Cu-1 and Cu-3 show a broad spectrum of cytotoxicity than Cu-2, and Cu-1 is more cytotoxic than Cu-3. What's interesting is that Cu-1 can exhibit obvious inhibitory effect on the growth of human triple-negative breast cancer in vivo and vitro through anti-proliferative, anti-angiogenic, anti-inflammatory, pro-apoptotic and cuproptotic synergistic effects. Though Cu-3 shows no significant cytotoxicity against MDA-MB-231 cells, it can significantly inhibit the growth of SKOV3 cells in vitro by down-regulating the expression of some key proteins in the VEGF/VEGFR2 signaling pathway and the expression of some pro-inflammatory cytokines, and by disrupting the balance of intracellular reactive oxygen species levels.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.